FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105135 [Registered on: 02/03/2026] Trial Registered Prospectively
Last Modified On: 01/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   A Study to Evaluate an Artificial Intelligence App for the Management of Computer Vision Syndrome and Dry EyE 
Scientific Title of Study   nil 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bhavna Tyagi 
Designation  Assistant professor 
Affiliation  Galgotias university 
Address  Aigin Royal,PLOT NO GH-D16, Greater Noida W Rd, Sector 1, Aimnabad, Greater Noida, Bisrakh Jalalpur, Uttar Pradesh 201318
Plot No.2, Sector 17-A Yamuna Expressway, Greater Noida, Gautam Buddh Nagar, Uttar Pradesh, India Opposite Buddh International Circuit.
Gautam Buddha Nagar
UTTAR PRADESH
201316
India 
Phone  6397686531  
Fax    
Email  tyagibhavna1999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Raj Kumar 
Designation  Professor 
Affiliation  Galgotias university 
Address  Seat no. 7 Room no 320 SAHS Department of optometry ,Plot No.2, Sector 17-A Yamuna Expressway, Greater Noida, Gautam Buddh Nagar, Uttar Pradesh, India Opposite Buddh International Circuit.Galgotias University Greater Noida
Plot No.2, Sector 17-A Yamuna Expressway, Greater Noida, Gautam Buddh Nagar, Uttar Pradesh, India Opposite Buddh International Circuit.
Gautam Buddha Nagar
UTTAR PRADESH
203201
India 
Phone  9015872988  
Fax    
Email  optomrajlvpei@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Bhavna Tyagi 
Designation  Assistant professor 
Affiliation  Galgotias university 
Address  Aigin Royal,PLOT NO GH-D16, Greater Noida W Rd, Sector 1, Aimnabad, Greater Noida, Bisrakh Jalalpur, Uttar Pradesh 201318
Plot No.2, Sector 17-A Yamuna Expressway, Greater Noida, Gautam Buddh Nagar, Uttar Pradesh, India Opposite Buddh International Circuit.

UTTAR PRADESH
201316
India 
Phone  6397686531  
Fax    
Email  tyagibhavna1999@gmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  Bhavna Tyagi 
Address  Seat Nn 37 Room no 320 Depatment of optometry SAHS Galgotias University Plot No2 Sector 17 A Yamuna Expressway Greater Noida Gautam Buddh Nagar Uttar Pradesh India 
Type of Sponsor  Other [self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raj Kumar  Galgotias University  Seat no 7 room no 320 Department of optometry SAHS Plot No 2 Sector 17A Yamuna Expressway opposite the Buddh International Circuit in Greater Noida Gautam Buddh Nagar Uttar Pradesh India 203201
Gautam Buddha Nagar
UTTAR PRADESH 
9015872988

optomrajlvpei@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
School ethics committee galgotias university  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Normal individuals working as academicians  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  VDT users more than 2 hours a day
Individuals who self-report symptoms associated with CVS and Dry Eye Syndrome specifically attributed to VDT use
Individuals who provide consent and compliance
Good general health based on sign and symptoms
 
 
ExclusionCriteria 
Details  Individuals with pre existing visual impairments or eye conditions or blepharospasm
Individuals with a history of eye surgery
Individuals who regularly wear contact lenses
Individuals with cognitive impairments or neurological conditions
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
This application will be work as prevention and management of computer vision syndrome
 
12 weeks
 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="292"
Sample Size from India="292" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study aims to develop and evaluate an artificial intelligence based application for the real-time assessment and management of Computer Vision Syndrome and Dry Eye Syndrome among individuals with prolonged digital screen exposure. CVS and DES are increasingly prevalent due to extensive use of computers and mobile devices, leading to symptoms such as eye strain, dryness, blurred vision, headaches, and visual fatigue, which adversely affect comfort, productivity, and quality of life.The proposed AI application will monitor user behavior and ocular indicators related to blink rate, screen usage patterns, and visual strain, and provide personalized, real-time recommendations to reduce symptom severity. The study addresses an existing research gap due to the limited availability of AI-based, user-friendly tools for continuous monitoring and early intervention in CVS and DES.The methodology involves human participants, with informed consent obtained, and does not include the use of human tissue or blood samples. Ethical considerations related to participant privacy, data security, and informed consent will be strictly followed. The expected outcome is a measurable reduction in CVS and DES symptoms, improved adherence to eye-health practices, and enhanced overall visual comfort through AI-driven monitoring and personalized management strategies.

 
Close